Episode 38 - Sanjeev Luther and Patient Life Quality Beyond Cures

My guest in this episode is Sanjeev Luther. Sanjeev is President & CEO of Ernexa Therapeutics. He is a seasoned life sciences leader with decades of experience in oncology, biotechnology innovation, and corporate leadership across global markets. He has guided clinical-stage biopharmaceutical companies through corporate strategy, R&D, licensing, regulatory affairs, and operations, overseeing global Phase 3 trials, major partnerships, and portfolio expansions in multiple therapeutic areas. His career includes senior roles at Cornerstone Pharmaceuticals, BMS, Novartis, Bausch and Lomb, and GE Healthcare, along with contributions to health policy initiatives such as Cures 2.0 and U.S. manufacturing efforts. Sanjeev also serves on the board of the South Asian Pharmaceutical Council and supports programs aiding adults with dementia. As CEO of Ernexa Therapeutics, he is advancing cell therapy innovations for cancer and autoimmune disease. In this chat, Sanjeev and I talk about: * the importance of extending life and enhancing the quality of life for patients * Curing diseases is not the only goal * Quality of life matters more than just survival * The importance of patient-centric perspectives in healthcare and * The need for a shift in how we view healthcare outcomes. I enjoyed my discussion with Sanjeev. I hope you do too. Here's Sanjeev Luther.

You can listen to Episode 38 - Sanjeev Luther and Patient Life Quality Beyond Cures online on Radio and Podcast. Open the player on this page to stream the available audio.

Episode 38 - Sanjeev Luther and Patient Life Quality Beyond Cures is an episode from The Future of Pharma by Samir Gondalia, ISPE Boston.

This episode is 33:16 long.

This episode was published on Dec 1, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from The Future of Pharma when more episodes are available from the podcast feed.